IDRA
Idera Pharmaceuticals Inc
Price:  
0.43 
USD
Volume:  
122,019.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IDRA EV/EBITDA

-
Upside

As of 2025-07-22, the EV/EBITDA ratio of Idera Pharmaceuticals Inc (IDRA) is -. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IDRA's latest enterprise value is 19.71 mil USD. IDRA's TTM EBITDA according to its financial statements is - mil USD. Dividing these 2 quantities gives us the above IDRA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative Enterprise Value.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples - -
Fair Price - -
Upside - -
0.43 USD
Stock Price
- USD
Fair Price

IDRA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA